Determinants of fracture risk in osteoporosis

Current Rheumatology Reports

Volumn 5, Issue 1, 2003, Pages 75-81

  Harvey, Nicholas ^b   Cooper, Cyrus ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b NONE

Author keywords

Bone Mineral Density; Fracture Risk; Raloxifene; Vertebral Deformity; Vertebral Fracture

Indexed keywords

CALCITRIOL RECEPTOR; COLLAGEN; CORTICOSTEROID;

ADDICTION; ADULT; AGED; ANTHROPOMETRY; FEMALE; FRACTURE; GENETICS; HEALTH BEHAVIOR; HUMAN; MALE; MIDDLE AGED; OSTEOPOROSIS; PLACENTA INSUFFICIENCY; PREGNANCY; REVIEW; RISK FACTOR;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTHROPOMETRY; COLLAGEN; FEMALE; FRACTURES, BONE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PLACENTAL INSUFFICIENCY; PREGNANCY; RECEPTORS, CALCITRIOL; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0037946791     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-003-0086-5     Document Type: Article

References (46)

1. Melton L, Cooper C: Magnitude and impact of osteoporosis and fractures. In In Osteoporosis, edn 2. Edited by Marcus R, Feldman D, Kelsey J. San Diego: Academic Press Inc; 2001:557–567.
2. Hunter D, de Lange M, Andrew T, et al.: Genetic variation in bone mineral density and calcaneal ultrasound: a study of the influence of menopause using female twins. Osteoporos Int 2001, 12:406–411. A good review. DOI: 10.1007/s001980170110
3. Kannus P, Palvanen M, Kaprio J, et al.: Genetic factors and osteoporotic fractures in elderly people: prospective 25 year follow-up of a nationwide cohort of elderly Finnish twins. BMJ 1999, 319:1334–1337. A large, long-term study indicating no increased concordance for fractures between monozygotic compared with dizygotic twins.
4. Ma X, Jing Y, Qin W, et al.: Vitamin D receptor gene polymorphism and bone mineral density in patients with type 2 diabetes mellitus. Chin Med J 2001, 114:1213–1215.
5. Pares A, Guanabens N, Alvarez L, et al.: Collagen type I alpha 1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 2001, 33:554–560. DOI: 10.1053/jhep.2001.22758
6. Vogelsang H, Suk E, Janisiw M, et al.: Calcaneal ultrasound attenuation and vitamin D receptor genotypes in celiac disease. Scand J Gastroenterol 2000, 35:172–176. DOI: 10.1080/003655200750024344
7. Langdahl B, Gravholt C, Brixen K, Eriksen E: Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures. Eur J Clin Invest 2000, 30:608–617. DOI: 10.1046/j.1365-2362.2000.00686.x
8. Dennison E, Arden N, Keen R, et al.: Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Pediatr Perinatal Epidemiol 2001, 15:211–219. Further evidence of genetic-environmental interaction. DOI: 10.1046/j.1365-3016.2001.00350.x
9. Hustmyer F, Liu G, Johnston C, et al.: Polymorphism at an Sp1 binding site of COL1A1 and bone mineral density in premenopausal female twins and elderly fracture patients. Osteoporos Int 1999, 9:346–350. DOI: 10.1007/s001980050157
10. Keen R, Woodford-Richens K, Grant S, et al.: Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum 1999, 42:285–290. DOI: 10.1002/1529-0131(199902)42:2<285::AID-ANR10>3.0.CO;2-3
11. Sainz J, Van Tornout J, Sayre J, et al.: Association of collagen type 1 alpha 1 gene polymorphism with bone density in early childhood. J Clin Endocrinol Metab 1999, 84:853–855. DOI: 10.1210/jc.84.3.853
12. Brown M, Haughton M, Grant S, et al.: Genetic control of bone density and turnover: role of collagen 1 alpha 1, estrogen receptor, and vitamin D receptor genes. J Bone Miner Res 2001, 16:758–764. A twin study showing an interaction between genetic polymorphisms, calcium intake, and BMD. DOI: 10.1359/jbmr.2001.16.4.758
13. Takacs I, Koller D, Peacock M, et al.: Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus. J Clin Endocrinol Metab 1999, 84:4465–4466. DOI: 10.1210/jc.84.12.4467
14. Wuster C, Abs R, Bengtsson B, et al.: The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001, 16:398–405. DOI: 10.1359/jbmr.2001.16.2.398
15. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, et al.: Serum interleukin-6 is a major predictor of bone loss in women specific to the first decade past menopause [abstract]. J Bone Miner Res 1999, 14(suppl):S147.
16. Ferrari S, Garnero P, Edmond S, et al.: A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum 2001, 44:196–201. DOI: 10.1002/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5
17. Keen R, Sneider H, Molloy H, et al.: Evidence of association and linkage dysequilibrium between a novel polymorphism in the transforming growth factor beta 1 gene and hip bone mineral density: a study of female twins. Rheumatology 2001, 40:48–54. DOI: 10.1093/rheumatology/40.1.48
18. Gong Y, Slee R, Fukai N, et al.: LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:513–523. DOI: 10.1016/S0092-8674(01)00571-2
19. Boyden L, Junhao M, Belsky J, et al.: High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002, 346:1513–1521. DOI: 10.1056/NEJMoa013444
20. Cooper C, Javaid M, Taylor P, et al.: The fetal origins of osteoporotic fracture. Calcif Tissue Int 2002, 70:391–394. DOI: 10.1007/s00223-001-0044-z
21. Sayer A, Dunn R, Langley-Evans S, Cooper C: Prenatal exposure to a maternal low protein diet shortens life span in rats. Gerontology 2001, 47:9–14. DOI: 10.1159/000052764
22. Gale C, Martyn C, Kellingray S, et al.: Intrauterine programming of adult body composition. J Clin Endocrinol Metab 2001, 86:267–272. An elegant study showing an association between birth weight and adult bone mineral content. DOI: 10.1210/jc.86.1.267
23. Dennison E, Hindmarsh P, Fall C, et al.: Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab 1999, 84:3058–3063. DOI: 10.1210/jc.84.9.3058
24. Godfrey K, Walker-Bone K, Robinson S, et al.: Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition and activity during pregnancy. J Bone Miner Res 2001, 16:1694–1703. Well-designed study showing the effect of maternal factors on neonatal bone mass. DOI: 10.1359/jbmr.2001.16.9.1694
25. Cooper C, Eriksson J, Forsen T, et al.: Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int 2001, 12:623–629. Convincing evidence for the influence of maternal and childhood influences on adult fracture risk. DOI: 10.1007/s001980170061
26. Javaid M, Godfrey K, Taylor P, et al.: Umbilical cord IGF-1 predicts neonatal bone and fat mass [abstract]. British Society for Rheumatology XIXth Annual General Meeting 2002. Rheumatology 2002, 41(suppl):5. DOI: 10.1093/rheumatology/41.1.5
27. Arden N, Dennison E, Syddall H, et al.: Early life influences on serum 1,25(OH)2 vitamin D [abstract]. British Society for Rheumatology XIXth Annual General Meeting 2002. Rheumatology 2002, 41(suppl):5. DOI: 10.1093/rheumatology/41.1.5
28. Phillips D, Fall C, Cooper C, et al.: Size at birth and plasma leptin concentrations in adult life. Int J Obesity 1999, 23:1025–1029. DOI: 10.1038/sj.ijo.0801050
29. Dennison E, Fall C, Syddall H, et al.: Plasma leptin concentration is associated with bone mass in healthy elderly men and women. [abstract] British Society for Rheumatology XIXth Annual General Meeting 2002. Rheumatology 2002, 41(suppl)1:97.
30. Roy D, Armbrecht G, Finn J, Felsenberg D, Lunt M, O’Neill T, Cooper C, Reeve J, Silman A: The influence of reproductive and lifestyle factors on the risk of incident vertebral fracture in women: results from the European Prospective Osteoporosis Study (EPOS) [abstract]. British Society for Rheumatology XIXth Annual General Meeting 2002. Rheumatology 2002, 41(suppl)1:6.
31. Scoutellas V, O’Neill T, Lunt M, et al.: Does the presence of postmenopausal symptoms influence susceptibility to vertebral deformity? European Vertebral Osteoporosis Study (EVOS) Group. Maturitas 1999, 32:179–187. DOI: 10.1016/S0378-5122(99)00025-0
32. Ismail A, Cockerill W, Cooper C, et al.: Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int 2001, 12:85–90. Large epidemiologic study showing increased risk of hip fracture with prevalent vertebral fracture. DOI: 10.1007/s001980170138
33. Ismail A, O’Neill T, Cooper C, Silman A: Risk factors for vertebral deformities in men: relationship to number of vertebral deformities. European Vertebral Osteoporosis Study Group. J Bone Miner Res 2000, 15:278–283. DOI: 10.1359/jbmr.2000.15.2.278
34. Lunt M, O’Neill T, Armbrecht G, et al.: Characteristics of prevalent vertebral deformity and the risk of incident vertebral fracture [abstract]. British Society for Rheumatology XIXth Annual General Meeting 2002. Rheumatology 2002, 41(suppl):101–102.
35. Lindsay R, Silverman S, Cooper C, et al.: Risk of new vertebral fracture in the year following a fracture. JAMA 2001, 285:320–323. DOI: 10.1001/jama.285.3.320
36. Cornuz J, Fesknich D, Willett W, Colditz G: Smoking, smoking cessation, and risk of hip fracture in women. Am J Med 1999, 106:311–314. DOI: 10.1016/S0002-9343(99)00022-4
37. Bjarnason N, Christiansen C: The influences of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 2000, 85:590–596. DOI: 10.1210/jc.85.2.590
38. Hoidrup S, Gronbaek M, Pederson A, et al.: Hormone replacement therapy and hip fracture risk: effect modification by tobacco smoking, alcohol intake, physical activity, and body mass index. Am J Epidemiol 1999, 150:1085–1093.
39. Chapurlat R, Ewing S, Bauer D, Cummings S: Influence of smoking on the antiosteoporotic efficacy of raloxifene. J Clin Endocrinol Metab 2001, 86:4178–4182. DOI: 10.1210/jc.86.9.4178
40. Sulzc P, Garnero P, Claustrat B, et al.: Increased bone resorption in moderate smokers with low body weight: the Minos study. J Clin Endocrinol Metab 2002, 87:666–674. DOI: 10.1210/jc.87.2.666
41. Liu X, Zhu Y, Umino T, et al.: Cigarette smoke inhibits osteogenic differentiation and proliferation of human osteoprogenitor cells in monolayer and three-dimensional collagen gel culture. J Lab Clin Med 2001, 137:208–219. DOI: 10.1067/mlc.2001.113066
42. Rapuri P, Gallagher J, Balhorn K, Ryschon K: Alcohol intake and bone metabolism in elderly women. Am J Clin Nutr 2000, 72:1206–1213.
43. Hoidrup S, Gronbaek M, Gottschau A, et al.: Alcohol intake, beverage preference, and risk of hip fracture in men and women: Copenhagen Center for Prospective Population Studies. Am J Epidemiol 1999, 149:993–1001. Clinically important evidence that excess alcohol increases risk of fracture.
44. Van Staa T, Leufkens H, Abenhaim L, et al.: Use of oral corticosteroids in the United Kingdom. Q J Med 2000, 93:105–111.
45. Van Staa T, Leufkens H, Abenhaim L, et al.: Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000, 15:993–1000. Clinically important data regarding the use of corticosteroids. DOI: 10.1359/jbmr.2000.15.6.993
46. Selby P, Halsey J, Adams K, et al.: Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 2000, 15:952–956. DOI: 10.1359/jbmr.2000.15.5.952